In DLBCL samples, the percentage of DNMT3A-positive tumor cells varied between 0% and 100% (Figure 4C and 4D) and the percentage of DOT1L-positive tumor cells between 1% and 85% (Figure 4G and H) (Supplementary Figure 5). This evidence concerns the gene DOT1L and diffuse large B-cell lymphoma.